Further Information
CD74, DHLAG, HLADG, Ia-GAMMA, CD74 molecule, major histocompatibility complex, class II invariant chain, CD74 antigen, CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated), HLA-DR-gamma, Ia-associated invariant chain, MHC HLA-DR gamma chain, gamma chain of class II antigens
Peptide ELISA: antibody detection limit dilution 1:128000.Western Blot:Approx 33kDa band observed in Human Tonsil lysates (calculated MW of 33.5kDa according to NP_001020330.1). Recommended concentration: 0.01-0.03ug/ml. Primary incubation was 1 hour. This antibody has been successfully used in WB: Meza-Romero R et al (2019). PMID: 30353480.
- Tian B, Zhang Y, Li N, Liu X, Dong J.CD74: a potential novel target for triple-negative breast cancer.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
The immunogen for this antibody is: C-HSLEQKPTDAPPK
972
CD74 molecule, major histocompatibility complex, class II invariant chain
CD74
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
Approx 33kDa
NP_001020330.1, NP_004346.1
20178292
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Obesity, Signal Transduction
This antibody is expected to recognize isoform a (NP_001020330.1) and isoform b (NP_004346.1).
P04233